Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX), Growpods Spotlighted in Borgen Magazine Article

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of self-contained, automated, indoor “micro-farms” called GrowPods, along with related equipment and supplies, were featured in an article published in Borgen magazine. The article, titled “How GrowPods Are Aiding Global Food Security,” notes that ACTX’s GrowPods “have the potential to help achieve global food security.” Noting that the consequences of global food insecurity are enormous, the article reports that Advanced Container Technologies and the innovative GrowPods may help solve the issue of global food shortages. Because the modular hydroponic farms can be located anywhere and provide an easily, accessible way to grow crops, GrowPods are a viable solution. The article also noted that GrowPods eliminate the problems of pests and disease. “Locusts and other insects ravage crops, destroying entire fields in the blink of an eye,” the article states, noting that the pods may help prevent nutrition as well. “Plants can pick up disease in any number of environments, as it is a long journey from field to consumer. . . .  The container farms perform equally well in rural and urban environments.”

For more information, view the full press release

About Advanced Container Technologies Inc.

Advanced Container Technologies is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer(R), that store and grind pharmaceuticals, herbs, teas and other solids or liquids. For more information, visit the company’s website at www.AdvancedContainerTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to ACTX are available in the company’s newsroom at https://cnw.fm/ACTX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Takes First Regulatory Step with FDA for Development of DehydraTECH-CBD in Treating Hypertension

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has successfully filed a pre-Investigational New Drug (“IND”) meeting request letter with the U.S. Food and Drug Administration (“FDA”). According to the update, the FDA has already responded to and confirmed Lexaria’s filing and has provided a target date of July 30, 2022, subject to certain conditions being met. “We are excited to take this important first regulatory step with the FDA for the development of our DehydraTECH-CBD for the treatment of hypertension,” said John Docherty, president of Lexaria. “Submission of this request letter initiates formal communication with the FDA regarding our IND clinical trial plans, in order to help define the critical path for clinical development and marketing approval of our potentially very significant new hypertension therapeutic.”

For more information, view the full press release

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 25 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Flora Growth Corp. (NASDAQ: FLGC) Bolsters its Global Expansion Strategy with Cannabis Regulatory Veteran Holly Bell’s Appointment; Hosts Regulatory Webinar

  • Flora Growth has appointed regulatory veteran Holly Bell as the new Vice President of Regulatory Affairs
  • Bell will help further the company’s domestic and global expansion strategy and lead government relations in key international markets
  • She will also oversee the regulatory strategy supporting the advancement of the company’s cultivation, distribution, and pharmaceutical programs
  • Bell also participated in the first event in her new position- the Florida Industrial Hemp Conference and Exhibition held on May 20-22, 2022

In recent months, Flora Growth (NASDAQ: FLGC) has been on an aggressive international expansion plan that has seen exports to Mexico and Spain, with an established presence in the U.K. and E.U.

In a move to strengthen the company’s global expansion strategy further, Flora Growth recently announced the appointment of regulatory veteran Holly Bell as the new Vice President of Regulatory Affairs. Bell will also be responsible for leading government relations in key international markets (https://cnw.fm/HxZ7j).

“I am excited to be working with Flora, supporting our work on the global stage, by advancing how the world views cannabis as a product and as a medicine,” she noted.

“I’m looking forward to leveraging my experience launching Florida’s hemp program to help Flora improve access to some of the best wellness brands in the world. From our leadership and brand teams to our valued scientists and cultivators, every part of the Flora organization is decided to providing safe, legal, and accessible cannabis products to consumers globally,” she added.

Bell has extensive experience in the cannabis sector, having worked as a cannabis consultant across the United States helping to build the infrastructure for industrial hemp programs. Most recently, she was the Florida Department of Agriculture and Consumer Services’ first Director of Cannabis. This agency fosters the creation of manufacturing, cultivation, and sales programs in the state. 

Through her previous positions, Bell has worked with leading regulators throughout Florida to create the first commercial hemp program in the state and develop an extensive educational series on the same program. She has also advised leading financial institutions on compliance to assist them in offering banking services to cannabis businesses.

“Holly’s unique knowledge and understanding of the United States’ regulatory framework will position us to make thoughtful, educated, and bold decisions regarding strategic distribution, cultivation, and sales plans,” noted Luis Merchan, Flora Growth’s President and Chief Executive Officer.

“We look forward to bringing Holly’s enterprise to our growing roster of industry standouts and working closely with governments worldwide to break down the barriers to the cannabis trade,” he added.

Bell will oversee the regulatory strategy supporting the advancement of Flora’s cultivation, distribution, and pharmaceutical programs, including its regulatory submissions and interactions with government authorities worldwide. She will also work towards developing and expanding a curriculum produced in partnership with EdEx that educates university students, companies, and governments about the business of cannabis.

The Florida Industrial Hemp Conference and Exhibition was Bell’s first event in her new position at Flora Growth. The event centered on advancing the industrial hemp industry in Florida and across the United States. Bell offered an overview of the state’s hemp program, which she helped leading state regulators develop (https://cnw.fm/poaqh).

The conference followed the Cannabis Regulatory Landscape webinar, where Bell, Jason Warnock, Flora Growth’s COO, and Mr. Merchan explored the nuances of working within the global cannabis regulatory framework. Discussions in the webinar included an overview of the opportunities and challenges for Flora and other cannabis companies operating in the U.S., Colombia, and other global markets, along with the importance of working closely with government entities.

The other topics covered in the webinar included what to expect from crucial bills to increase accessibility and market opportunities for Flora Growth and which markets continue to show substantial promise.

Bell holds a bachelor’s degree in Agricultural Economics from Purdue University and is a tenured consultant with experience working in the entertainment, cannabis, and banking spaces.

For more information, visit the company’s website at www.FloraGrowth.com.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Cannabis MSOs Hire Prominent Law Firm to Sue Federal Government

Some cannabis firms and stakeholders have joined forces to take the U.S. federal government to court because of policies that they consider to be violate the constitution. They hope to triumph over these prohibition policies, which they argue have impeded their operations. Boies Schiller Flexner LLP will represent the multistate operators’ coalition in court.

David Boies, chairman of the selected law firm, has been involved in a number of high-profile federal cases. The firm’s clientele list has included former U.S. vice president Al Gore and the Justice Department as well as the plaintiffs during the case that led to reversing the ban of same-sex marriages in the state of California.

In a recent interview, Ascend Wellness Holdings CEO and founder Abner Kurtin stated that the suits were an undertaking involving the entire cannabis industry and included one suit which would challenge the 280E provision that hinders the marijuana industry from receiving tax deductions which other companies can take. Another suit is focused on preventing the federal government from impeding marijuana commerce across state borders.

TerrAscend and Curaleaf as well as the American Trade Association of Cannabis and Hemp (ATACH) are some of the prospective supporters of this initiative. ATACH President Michael Bronstein stated in an interview that the group believed that the Internal Revenue Code’s 280E provision and the Controlled Substances Act weren’t being properly applied to legitimate businesses. While he didn’t reveal that ATACH was involved in the ongoing litigation effort, Bronstein did add that the organization was focused on continuing to explore and assess the possible legal options.

The organizations plan to file a pair of lawsuits in federal district court, one of which will call into question the Controlled Substances Act’s constitutionality, and the other, which will take aim at the Internal Revenue Code. The Internal Revenue Code doesn’t allow marijuana businesses to claim federal tax deductions because they are considered to be trafficking in controlled substances.

This IRS issue being resolved could allow marijuana companies that haven’t been able to access federal tax relief to amend their prior tax returns and take deductions.

If the challenge to the status of cannabis under the Controlled Substances Act is successful, this may afford marijuana businesses access to both major stock exchanges and the banking system. Currently, cannabis businesses are operating mostly on a cash-only basis, which makes them targets of crime. This comes as advocates, congressional legislators and state officials have been calling for the SAFE Banking Act to be approved.

At this point, however, it is yet to be determined which federal district courts the suits will be filed in. Plant-touching and ancillary companies such as Advanced Container Technologies Inc. (OTC: ACTX) are likely to follow this particular case since it has potentially huge ramifications for the cannabis industry.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Ukraine War, Supply Chain Issues Increase Marijuana Production Costs

Ever since the supply chain problems triggered by the pandemic were worsened by Russia’s invasion of Ukraine, cannabis producers are facing rising costs that could shake the industry in ways that have never been seen.

Russia and Ukraine together account for 28% of NPK fertilizers (nitrogen, phosphorous as well as potassium) sold on the world market. The war and the sanctions placed on Russia have shaken this supply source, and the cannabis industry as well as other segments of the agricultural industry is feeling the heat.

“Modern Farmer,” a magazine published every quarter, paints a graphic picture of how fertilizer prices have gone up in recent times. It writes that the price of anhydrous ammonia has risen by 225%, while the price of liquid nitrogen has gone up by 192%. Urea has seen a 149% price hike over the past 12 months.

The news agency Reuters also estimates that after registering a 17% price increase last year, fertilizer prices are likely to increase by at least 12% this year.

These price increases are so serious that the U.S. federal government announced in June that it plans to double its initial investment of $250 million so that efforts to produce fertilizers locally are boosted. However, the cannabis industry isn’t too excited about this development because the feds are likely to be more interested in supporting farmers of crops such as soy or corn rather than spreading the benefits of this push across the board.

These price increases as well as the supply chain hiccups that started when the pandemic struck suggest that players in the cannabis industry need to be innovative and find ways to weather this storm. For example, there is need to rethink how procurement is done so that companies can buy in bulk instead of buying small batches of inputs at the precise moment when those inputs are needed. This consolidation will ensure that the cultivators get what they need and at reasonable prices instead of buying at a higher price each time they reenter the market.

Producers can also become more conscious about fertilizer use in order to use just enough to give the expected yield without anything going to waste. For example, many fertilizer manufacturers recommend product usage that is at the higher end of the spectrum, but cannabis plants can grow well with much less fertilizer application.

Technologies such as electrical activity monitors can also alert farmers when their fertilizer use has reached the optimum level, hence preventing waste during cultivation. Regenerative farming methods can enable cultivators to depend on fewer artificial inputs, thereby cushioning themselves from the inflation affecting conventional growers.

While the shocks the industry is facing are the same, they aren’t affecting all industry players, including American Cannabis Partners, in the same way since these external factors normally find a differing mix of internal efficiencies or weaknesses.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Advanced Container Technologies Inc.’s (ACTX) Innovative Growing Systems Offering Numerous Advantages

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of GrowPods, is seeing interest in the environmentally controlled micro-farms that allow cultivation of ultraclean crops year-round. According to a recent article that contains excerpts from a GreenBiz piece titled, “How Vertical and Indoor Farming Can Supplement the Food Supply Chain,” innovators have developed new technologies such as indoor and vertical farms designed to supplement outdoor farming and solve the issue of limited cultivation land. The piece notes that “the systems often recirculate water, which can be more efficient than how water is used for other types of crops. Light and temperature can also be controlled, and since there is no exposure to pests, no chemistry is needed…. [The farms] can be built anywhere. That means food such as leafy greens can be grown closer to population centers.” Experts also believe that while indoor and vertical farming will not feed the world, it can supplement the supply chain. “These are only a few of the advantages that GrowPods, which are self-contained, automated, indoor micro-farms, offer users. These innovative containerized growing systems are designed with functionality and ease of use in mind. The pods are configured to optimize plant growth while minimizing labor; setup is quick and simple, no pesticides are needed, and the containers produce harvests all year long.”

To view the full article, visit https://cnw.fm/vrVue

About Advanced Container Technologies Inc.

Advanced Container Technologies is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer(R), that store and grind pharmaceuticals, herbs, teas and other solids or liquids. For more information, visit the company’s website at www.AdvancedContainerTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to ACTX are available in the company’s newsroom at https://cnw.fm/ACTX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Awards Exclusive License to Japan’s Premier Wellness Science Co.

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has awarded licensing of its proprietary DehydraTECH(TM) offering for development in Japan to Premier Wellness Science Co. Ltd, a wholly owned subsidiary of Premier Anti-Aging Co. Ltd. LEXX announced that Premier is purchasing exclusive rights to DehydraTECH technology for the Japanese nonpharmaceutical market; the company will use the tech in oral liquid and nonliquid products, as well as for topical, hair-care, lip-care and cosmetics products. According to the announcement, Lexaria will receive minimum payments of $4,527,500 over the next five years, as all well as royalties from the sales of products made with DehydraTECH, which the company anticipates could be significantly greater than the minimum payments. In addition, the two companies agreed to explore the possibility of R&D collaborations. An official from Premier noted that the company partnered with Lexaria based on DehydraTECH’s superior performance and the extensive data available through Lexaria’s years of testing. “Lexaria is delighted to be working with Premier Wellness Science, which we expect will dominate the newly opening Japanese market for CBD-based products,” said Lexaria CEO Chris Bunka in the press release. “Premier and Lexaria share similar philosophies, such as the provision of world-leading products created through scientific advantages and placing the consumer’s needs ahead of our own. We could not have found a better partner with which to introduce DehydraTECH-enabled products to the Japanese markets.”

For more information, view the full press release

About Lexaria Bioscience Corp.

Lexaria Bioscience’s patented drug-delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 25 patents granted and more than 50 patents pending worldwide. For more information about the company, please visit www.LexariaBioscience.com. 

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Lexaria Bioscience Corp. (NASDAQ: LEXX) Mines Potential of Helping Medicines Do What they Do, But Better

  • Lexaria Bioscience is a global innovator in drug delivery platforms, developing a technology designed to improve the performance of other medicinal products by making them more rapidly and effectively usable by patients’ bodies
  • Lexaria’s patented DehydraTECH technology has been studied in combination with a number of other products, including but not limited to, cannabidiol (“CBD”), oral nicotine, antivirals, NSAIDs, and erectile dysfunction therapies
  • The company is pursuing FDA approval under the Investigational New Drug (“IND”) process to clinically test its DehydraTECH-CBD for the treatment of high blood pressure
  • A driving focus of the company’s R&D has been to improve the speed of onset, increase bioavailability and brain absorption of active pharmaceutical ingredients

A common refrain in the world of advertising medicinal substances is that a select product can enhance a patient’s ability to live an active life despite debilitating medical conditions. 

“By helping to control eczema with Dupixent you can show more (skin),” one prominent ad message declared in recent months, while another offered examples of hope by testifying, “Opdivo plus Yervoy equals a chance for more starry nights” (https://cnw.fm/yBxCG). 

Drug delivery innovator Lexaria Bioscience (NASDAQ: LEXX) has found a market niche in the potential of enhancing medicines’ ability to do what they do. The company’s patented DehydraTECH(TM) technology has been tested in combination with a variety of active pharmaceutical ingredients (“APIs”), processing the drug substances through a proprietary dehydration process for rapid-absorption delivery. 

“Lexaria has repeatedly demonstrated that DehydraTECH-processed cannabidiol (‘CBD’) has superior delivery characteristics into the bloodstream and brain compared to generic CBD and expects to generate similar results with THC,” the company stated in regard to one set of substances last year (https://cnw.fm/jiX9J).

Lexaria is pursuing U.S. Food and Drug Administration (“FDA”) approval to begin formal, registered clinical testing for using DehydraTECH-CBD to treat hypertension following a series of successful studies.

“Lexaria has repeatedly demonstrated that DehydraTECH-processed nicotine has superior delivery characteristics compared to generic nicotine when dosed orally and swallowed for intestinal delivery to the bloodstream,” the company added in regard to another progressing area of R&D.

“Phosphodiesterase-5 inhibitor (PDE5) drugs work using a process of vasodilation, and most are considered to be slow-acting, requiring 1-2 hours to reach peak levels in the bloodstream for maximum effectiveness,” Lexaria stated in regard to still other products treating erectile dysfunction (“ED”). “Lexaria has repeatedly evidenced a greatly reduced delivery time of another drug that encourages vasodilation – DehydraTECH CBD – and theorizes whether DehydraTECH might likewise deliver PDE5 drugs more quickly and effectively. … DehydraTECH for PDE5 drugs is patent pending.”

 The Company recently announced its 25th patent has been awarded for for the use of DehydraTECH technology in the enhanced delivery of antiviral drugs — its first patent to build on studies processing antivirals such as remdesivir and ebastine with DehydraTECH to fight the COVID-19/SARS-CoV-2 virus and other biosystem invaders (https://cnw.fm/Re39u).

Lexaria will commence its human oral nicotine study NIC-H22-1 this summer.  The Company is optimistic that this larger human study will produce positive findings pursuant to those evidenced in its previous 2021 subjective human testing that utilized DehydraTECH-nicotine formulations demonstrating onset of initial nicotine effectiveness in as little as 1.5 to 4 minutes after an oral dose. As the body of data regarding DehydraTECH has grown, its use in improving outcomes for a variety of conditions has generated widespread corporate optimism.

“If we can sustain these results, we could be looking at mega-drug status ($1 billion per year) in the hypertension market,” CEO Chris Bunka stated last year in regard to the DehydraTECH-CBD studies (https://cnw.fm/WRGRV). “Our goal now is to put together a 4-week study, three doses per day, targeting a sustained drop in blood pressure. That could make us one of the most effective registered pharmaceutical treatments for hypertension in the world, with few if any unwanted side effects.”

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — DOJ Report Says Federal Cannabis Arrests Continue to Decline Annually

According to new data released by the U.S. Department of Justice, federal arrests connected to marijuana have continued to plummet each year as states continue reforming their cannabis laws and creating markets for this substance. The report says that the number of people arrested by the U.S. Drug Enforcement Administration has registered an annual 11% decline from 2010. In that year, a total of 8,215 arrests connected to marijuana charges were made by the federal agency. However, the figure has dropped over time to the 2,576 arrests on record in 2020.

It isn’t immediately clear which specific factors are behind the drop in arrests, but the DEA says the COVID-19 pandemic, which was at its peak in 2020, was responsible for a huge decline (81%) in the number of people arrested on marijuana charges between March and April 2020, when stay-at-home orders had just been issued across the country. During those two months, cannabis prosecutions also registered a 77% slump.

However, marijuana industry advocates see the reason for the drop in a different way. They think that the Department of Justice has used its discretionary powers to refrain from pursuing low-level marijuana infractions, especially since the guidance provided during President Barack Obama’s time in the Oval Office urged the department to be less vigilant in going after marijuana users in states where such possession or use is permitted. The wave of cannabis legalization has also had a hand in reducing the frequency of arrests by the DEA, advocates say.

Of all the arrests connected to drugs, only 16% of those arrests were connected to marijuana. The vast majority of the arrests were related to methamphetamine, heroin and cocaine in powder form. The report clearly shows that of all drugs, cannabis has registered the steepest slump in the number of arrests conducted by the DEA.

It is also noteworthy that the DEA report says that most people serving time in federal prisons have a drug charge as the most serious offense they face. In fact, nearly half (47%) of the entire prison population have a drug charge to their name. In 2010, the fraction stood at 53%, so there is a decline in that regard as well.

Data from different sources backs up the findings of the DOJ. For example, the FBI authored a report in 2020 showing a nationwide drop in cannabis-related arrests. Also, 2018 research conducted by the Cato Institute concluded that the legalization of marijuana in different states had significantly reduced the rate at which marijuana was being smuggled into the country.

These statistics may indirectly suggest that the marijuana consumers have come to trust the products commercialized by licensed marijuana companies such as Flora Growth Corp. (NASDAQ: FLGC) in the jurisdictions where such companies are allowed to operate.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Georgia Voters Endorse Ballot Question on Cannabis Legalization

Earlier last week, voters in the state of Georgia approved the language of a ballot measure expressing support for the legalization of adult-use marijuana. Democratic Party leadership in the state placed a number of nonbinding advisory questions on the primary election ballot to help inform lawmakers on where residents in the state stood on various issues, including cannabis legalization.

The question on legalization asked residents whether cannabis needed to be legalized, regulated and taxed in the same manner as alcohol for individuals aged 21 and above, with proceeds from its sale being directed toward health care, infrastructure and education programs. The cannabis initiative led by a strong margin of 80% with more than 99% of the counties having reported full results. While the vote’s results don’t change the state’s law, the high numbers of those in favor of legalization highlight the support for reform.

The state has open primaries, which means that any voter in Georgia could fill out the Democratic ballot on the day of election, regardless of what party they belonged to.

In addition to the question on marijuana legalization, questions on renewable energy, health care, free preschool, paid parental leave and the forgiveness of student loans were asked on the Democratic ballot. Meanwhile, the Republican ballot afforded individuals in the state a chance to comment on social media censorship, the right of transgender individuals to participate in sports and the Mexican border wall.

It should be noted that during this session, reforms to the state’s limited medical marijuana program advanced in both chambers but failed to be approved at the final passage.

In the past, Senate Democrats in the state of Georgia also tried enacting a measure that included provisions to decriminalize low-level possession of marijuana in 2020. However, the measure didn’t advance. This came after Democratic primary voters in the state of South Carolina were asked about their stance on the legalization of medical marijuana at the ballot in 2018. More than 80% of the voters’ response was in support of enacting a change in policy that would allow patients access to cannabis.

Last year, legislators in the Minnesota House also conducted a survey of residents as part of the State Fair Poll. Among the questions asked on the poll was how many were in favor of the legalization of adult-use marijuana. Results indicated that 58% of those who responded were in favor of reform. This figure was a slight increase in comparison to the 2019 survey that asked the same question, which found that 56% of the respondents would back the reform.

As many more states work to ease their cannabis prohibition policies, established cannabis companies such as Cannabis Strategic Ventures Inc. (OTC: NUGS) could end up spreading their footprint across state lines, especially when federal cannabis legalization takes place.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.